Does AVAPRITINIB Cause Product dose omission issue? 385 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 385 reports of Product dose omission issue have been filed in association with AVAPRITINIB (Ayvakit). This represents 3.8% of all adverse event reports for AVAPRITINIB.
385
Reports of Product dose omission issue with AVAPRITINIB
3.8%
of all AVAPRITINIB reports
4
Deaths
48
Hospitalizations
How Dangerous Is Product dose omission issue From AVAPRITINIB?
Of the 385 reports, 4 (1.0%) resulted in death, 48 (12.5%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AVAPRITINIB. However, 385 reports have been filed with the FAERS database.
What Other Side Effects Does AVAPRITINIB Cause?
Fatigue (1,527)
Off label use (1,138)
Nausea (1,033)
Diarrhoea (886)
Swelling face (481)
Memory impairment (467)
Dizziness (458)
Vomiting (456)
Headache (454)
Asthenia (433)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which AVAPRITINIB Alternatives Have Lower Product dose omission issue Risk?
AVAPRITINIB vs AVASTIN
AVAPRITINIB vs AVATROMBOPAG
AVAPRITINIB vs AVELOX
AVAPRITINIB vs AVELUMAB
AVAPRITINIB vs AVIBACTAM